购物车
您的购物车当前为空
别名 NXL-101, NXL101, NXL 101
Viquidacin ( NXL-101) is an oral/intravenous antibiotic that targets Gram-positive bacteria such as MRSA. In 2008, Novexel announced it had discontinued the development of Viquidacin (NXL 101).

Viquidacin ( NXL-101) is an oral/intravenous antibiotic that targets Gram-positive bacteria such as MRSA. In 2008, Novexel announced it had discontinued the development of Viquidacin (NXL 101).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 待询 |
| 产品描述 | Viquidacin ( NXL-101) is an oral/intravenous antibiotic that targets Gram-positive bacteria such as MRSA. In 2008, Novexel announced it had discontinued the development of Viquidacin (NXL 101). |
| 别名 | NXL-101, NXL101, NXL 101 |
| 分子量 | 504.64 |
| 分子式 | C25H29FN2O4S2 |
| CAS No. | 904302-98-3 |
| Smiles | [C@@H](CC[C@H]1[C@@H](C(O)=O)CN(CCSC2=CC=CS2)CC1)(O)C=3C4=C(C=CC(OC)=C4)N=CC3F |
| 密度 | 1.37 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多